Table 2.
Comparison of factors associated with not meeting the 45-day surgery benchmark.
| Patient characteristic (n=322a) | > 45 days (N= 71, 22%), n (%) |
≤ 45 days (N= 250, 78%), n (%) |
P value |
|---|---|---|---|
| Age, mean (SD), y | 59 (14) | 62 (13) | .039 e |
| Race/ethnicity | .221d | ||
| White | 47 (67) | 178 (72) | |
| Chinese origin | 8 (11) | 30 (12) | |
| Black/African-American | 7 (10) | 28 (11) | |
| Others | 9 (13) | 11 (4) | |
| Language | .715c | ||
| English | 62 (87) | 210 (85) | |
| All others | 9 (13) | 38 (15) | |
| Census tract median household income, median (25th-75th percentiles), $ | 64,675 (50,934–79,492) | 77,845 (60,589–94,891) | 0.003 f |
| Insurance | .903c | ||
| Private only | 28 (39) | 101 (41) | |
| Any subsidizedb | 42 (59) | 141 (57) | |
| Married / Partnered | 43 (61) | 135 (54) | .435c |
| Tumor stage | .303d | ||
| I | 42 (59) | 170 (69) | |
| II | 22 (31) | 60 (24) | |
| III | 7 (10) | 18 (7) | |
| ER- and/or PR-positive | 55 (77) | 224 (91) | .005 c |
| HER2-positive | 10 (14) | 25 (10) | .475c |
| Had multiple biopsies | 12 (18) | 28 (12) | .275c |
| Had family history of breast cancer | 26 (39) | 115 (47) | .283c |
| Had prior history of breast cancer treatment | 9 (13) | 23 (9) | .502c |
| Had any comorbidity (Charlson score 1–8) | 33 (46) | 80 (33) | .043 c |
| Type of surgery | <.001 c | ||
| Lumpectomy | 33 (46) | 185 (75) | |
| Mastectomy | 37 (53) | 60 (24) |
Bold denotes P < .05.
Abbreviations: ER = estrogen receptor; HER2 = human epidermal growth factor receptor 2; PR = progesterone receptor; SD = standard deviation.
a
Stage I to III patients who had surgery recommended as the first treatment and received surgery.
b
”Any subsidized” includes any Medicare, MassHealth (MA Medicaid), and/or any health insurance exchange product.
c
X2 test.
d
Fisher exact test.
e
t test.
f
Mann-Whitney test.